source
stringlengths 2
222
| date
stringlengths 19
19
| url
stringlengths 22
853
⌀ | text
stringlengths 0
10k
⌀ | title
stringlengths 0
701
| context_id
stringlengths 1
9
| document_id
stringclasses 2
values | document_type
stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-05-05 11:30:00
| null |
GREEN PLAINS TO SUPPLY XEROX WITH FDA APPROVED FCC GRADE ALCOHOL.GREEN PLAINS - SUPPLYING FDA APPROVED, FCC GRADE ALCOHOL TO XEROX HOLDINGS FOR USE IN THEIR PRODUCTION OF NEW LINE OF HOSPITAL GRADE HAND SANITIZERS.GREEN PLAINS - CO'S ETHANOL SUPPLY ALLOWS XEROX TO DELIVER UPWARDS OF 140,000 GALLONS TO HEALTHCARE ORGANIZATIONS IN U.S. & CANADA BY JUNE.
|
GREEN PLAINS TO SUPPLY XEROX WITH FDA APPROVED FCC GRADE ALCOHOL
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-04-28 10:30:00
| null |
XEROX RELEASES FIRST-QUARTER RESULTS.Q1 GAAP LOSS PER SHARE $0.03 FROM CONTINUING OPERATIONS.Q1 REVENUE $1.86 BILLION VERSUS REFINITIV IBES ESTIMATE OF $1.72 BILLION.Q1 EARNINGS PER SHARE ESTIMATE $0.36 -- REFINITIV IBES DATA.WITHDRAWS 2020 FINANCIAL GUIDANCE DUE TO ECONOMIC UNCERTAINTY CAUSED BY COVID-19.QTRLY ADJUSTED EARNINGS PER SHARE (EPS) OF $0.21.EFFECTS OF COVID-19 PANDEMIC HAVE MATERIALLY AFFECTED HOW WE AND OUR CUSTOMERS ARE OPERATING OUR BUSINESSES.XEROX - DURATION & EXTENT TO WHICH COVID-19 PANDEMIC WILL IMPACT FUTURE RESULTS OF OPERATIONS & OVERALL FINANCIAL PERFORMANCE REMAIN UNCERTAIN.XEROX - BASE MODEL FOR COVID-19 IMPACT ASSUMES GREATEST IMPACT TO REVENUE FROM BUSINESS CLOSURES DURING Q2, WITH INFLECTION POINT LATE IN THAT PERIOD, GRADUAL RECOVERY IN Q3.XEROX HOLDINGS - FOR Q4, EXPECT TO GET CLOSER TO OUR PLANNED LEVELS FOR THAT PERIOD.XEROX HOLDINGS - MOST SIGNIFICANT NEAR-TERM IMPACT FROM COVID-19 CRISIS IS ON EQUIPMENT & UNBUNDLED SUPPLIES SALES WHICH ARE TRANSACTIONAL IN NATURE.XEROX HOLDINGS - EXPECT EQUIPMENT AND UNBUNDLED SUPPLIES SALES TO REBOUND IN SECOND HALF AS BUSINESSES REOPEN.XEROX HOLDINGS - GLOBAL COVID-19 PANDEMIC CRISIS SIGNIFICANTLY IMPACTED Q1 2020 REVENUES DUE TO BUSINESS CLOSURES DURING MONTH OF MARCH.Q1 TOTAL REVENUE INCLUDES 0.8-PERCENTAGE POINT UNFAVORABLE IMPACT FROM CURRENCY.IN NORTH AMERICA, BUSINESS SHUTDOWNS IMPACTED CO'S OPERATIONS IN SECOND PART OF MARCH ONLY.
|
XEROX WITHDRAWS 2020 GUIDANCE DUE TO ECONOMIC UNCERTAINTY CAUSED BY COVID-19
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-04-08 09:30:00
| null |
XEROX HOLDINGS SAYS CEO GIOVANNI (JOHN) VISENTIN'S FY 2019 TOTAL COMPENSATION WAS $13.1 MILLION VERSUS $23.5 MILLION IN 2018 - SEC FILING.XEROX HOLDINGS CORP SAYS FOR 2019, PAY RATIO WAS 159 TO 1.
|
XEROX SAYS CEO GIOVANNI VISENTIN'S FY 2019 TOTAL COMPENSATION WAS $13.1 MLN
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-03-31 20:30:00
| null |
XEROX PROVIDES UPDATE ON PROPOSAL TO ACQUIRE HP.WITHDRAWING OUR TENDER OFFER TO ACQUIRE HP.WILL NO LONGER SEEK TO NOMINATE SLATE OF CANDIDATES TO HP'S BOARD.CURRENT GLOBAL HEALTH CRISIS, MARKET TURMOIL HAVE CREATED AN ENVIRONMENT THAT IS NOT CONDUCIVE TO XEROX CONTINUING TO PURSUE ACQUISITION OF HP.
|
XEROX DROPS BID TO ACQUIRE HP
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-03-31 18:30:00
| null |
:XEROX TO END HOSTILE TAKEOVER BID FOR HP
|
XEROX TO END HOSTILE TAKEOVER BID FOR HP - WSJ
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-03-25 18:30:00
| null |
HP ISSUES LETTER TO SHAREHOLDERS.HP INC SAYS "BELIEVE XEROX PROPOSAL FUNDAMENTALLY UNDERVALUES HP".HP SAYS "WE REMAIN OPEN-MINDED ABOUT M&A AS A TOOL TO ADD VALUE FOR HP SHAREHOLDERS AT RIGHT TIME AND ON RIGHT TERMS".HP INC ON M&A SAYS "IT'S ABUNDANTLY CLEAR THAT NOW IS NOT THAT TIME".HP INC SAYS HAVE A HEALTHY CASH POSITION AND BALANCE SHEET THAT HELPS CO TO NAVIGATE UNANTICIPATED CHALLENGES SUCH AS CRISIS NOW.
|
HP INC ON M&A SAYS "IT'S ABUNDANTLY CLEAR THAT NOW IS NOT THAT TIME"
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-03-05 09:30:00
| null |
HP REJECTS UNSOLICITED EXCHANGE OFFER FROM XEROX.HP INC - BOARD BELIEVES XEROX OFFER "MEANINGFULLY UNDERVALUES HP AND DISPROPORTIONATELY BENEFITS XEROX SHAREHOLDERS".HP INC - HP BOARD UNANIMOUSLY RECOMMENDS THAT HP SHAREHOLDERS REJECT OFFER AND NOT TENDER THEIR HP SHARES PURSUANT TO OFFER.HP INC SAYS HP BOARD BELIEVES THAT HP'S STANDALONE PLAN HAS POSITIONED HP FOR "SIGNIFICANT VALUE CREATION".HP INC - HP BELIEVES THAT XEROX'S "SYNERGY" ESTIMATES, INCLUDING COST CUTS, EXCEED REASONABLY ACHIEVABLE LEVELS.HP INC SAYS XEROX OFFER INCLUDES SIGNIFICANT EQUITY COMPONENT, VALUE OF WHICH HP BOARD BELIEVES WOULD BE SUBJECT TO SIGNIFICANT RISKS, UNCERTAINTIES.HP - BOARD GOT INADEQUACY OPINION FROM GOLDMAN SACHS & GUGGENHEIM SECURITIES THAT AS OF MARCH 3 XEROX OFFER WAS INADEQUATE FROM FINANCIAL POINT OF VIEW.HP INC SAYS HP BELIEVES THAT XEROX'S COST-CUTTING HAS COME AT "EXPENSE OF LONG-TERM VALUE CREATION".
|
HP REJECTS UNSOLICITED EXCHANGE OFFER FROM XEROX
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-03-02 10:30:00
| null |
XEROX SAYS ENTERED INTO AMENDED & RESTATED COMMITMENT LETTER, DATED AS OF FEBRUARY 26, 2020 - SEC FILING.
|
XEROX SAYS ENTERED INTO AMENDED & RESTATED COMMITMENT LETTER, DATED AS OF FEBRUARY 26, 2020
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-02-27 12:30:00
| null |
XEROX - ANNOUNCES LAUNCH OF VIRTUAL PRINT MANAGEMENT SERVICE AND WORKPLACE CLOUD FLEET MANAGEMENT.
|
XEROX - ANNOUNCES LAUNCH OF VIRTUAL PRINT MANAGEMENT SERVICE AND WORKPLACE CLOUD FLEET MANAGEMENT
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-02-24 19:30:00
| null |
HP ANNOUNCES STRATEGIC AND FINANCIAL VALUE CREATION PLAN.HP INC - EXPECTS TO DELIVER NON-GAAP DILUTED NET EARNINGS PER SHARE OF $3.25 TO $3.65 IN FISCAL 2022.HP INC - ANNOUNCES $15 BILLION TOTAL SHARE REPURCHASE AUTHORIZATION PROGRAM.HP INC - TARGETS $16 BILLION CAPITAL RETURN PLANNED OVER THREE YEARS.HP INC - PLANS AT LEAST $8 BILLION SHARE REPURCHASE WITHIN 12 MONTHS FOLLOWING ITS ANNUAL MEETING.HP -EXPECTS TO GENERATE $1.2 BILLION STRUCTURAL COST REDUCTIONS IN FISCAL 2022 WITH FLOW THROUGH TO NON-GAAP OPERATING PROFIT OF APPROXIMATELY $650 MILLION.HP INC - EXPECTS ABOUT $650 MILLION OF STRUCTURAL COST SAVINGS FLOW THROUGH TO PROJECTED NON-GAAP OPERATING PROFIT GROWTH FROM COST REDUCTION PROGRAM.HP INC - IN PRINT, ESTABLISHING LONG-TERM TARGET OPERATING MARGIN RANGE OF 16% TO 18%.HP - REACHING OUT TO XEROX TO EXPLORE IF THERE IS A COMBINATION THAT "CREATES VALUE" FOR SHAREHOLDERS THAT IS ADDITIVE TO STRATEGIC, FINANCIAL PLAN.HP- SEES IMPLEMENTATION OF CAPITAL RETURN PROGRAM TO INCLUDE REPURCHASE OF AT LEAST $8 BILLION OF HP SHARES OVER 12 MONTHS FOLLOWING HP'S 2020 ANNUAL MEETING.HP INC - EXPECTS TO GENERATE $10.7 BILLION TO $11.7 BILLION OF CUMULATIVE FREE CASH FLOW IN FISCAL 2020 THROUGH FISCAL 2022.HP - EXPECTS TO GENERATE $1.2 BILLION STRUCTURAL COST REDUCTIONS IN FISCAL 2022 WITH FLOW THROUGH TO NON-GAAP OPERATING PROFIT OF APPROXIMATELY $650 MILLION.HP INC - INTENDS TO MAINTAIN DIVIDEND PER SHARE GROWTH AT LEAST IN LINE WITH EARNINGS.
|
HP INC SAYS EXPECTS TO DELIVER NON-GAAP DILUTED NET EARNINGS PER SHARE OF $3.25 TO $3.65 IN FISCAL 2022
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-02-24 12:30:00
| null |
XEROX NAMES XAVIER HEISS EVP AND PRESIDENT OF EMEA OPERATIONS.XEROX HOLDINGS - HEISS WILL SUCCEED HERVÉ TESSLER FOLLOWING HIS RETIREMENT FROM XEROX AT END OF FEBRUARY.
|
XEROX NAMES XAVIER HEISS EVP AND PRESIDENT OF EMEA OPERATIONS
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-02-20 20:30:00
| null |
HP ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS PLAN.HP INC - DECLARED A DIVIDEND DISTRIBUTION OF ONE PREFERRED SHARE PURCHASE RIGHT ON EACH OUTSTANDING SHARE OF HP COMMON STOCK..HP INC - SETS TRIGGER AT 20%.HP INC - RIGHTS PLAN WILL NOT PREVENT A COMBINATION OF HP WITH ANOTHER BUSINESS.HP INC - RIGHTS PLAN "SHOULD ENCOURAGE" XEROX TO NEGOTIATE WITH BOARD.HP INC - EACH RIGHT WILL ENTITLE ITS HOLDER TO PURCHASE FOR $100, A NUMBER OF HP COMMON SHARES HAVING A MARKET VALUE OF TWICE SUCH PRICE.HP - AT ANY TIME AFTER PERSON/GROUP ACQUIRES 20% OR MORE OF COMMON STOCK, BOARD MAY EXCHANGE ONE SHARE OF CO'S COMMON STOCK FOR EACH OUTSTANDING RIGHT.HP INC - RIGHTS WILL EXPIRE ON FEBRUARY 20, 2021..
|
HP ADOPTS LIMITED DURATION SHAREHOLDER RIGHTS PLAN
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-02-03 15:30:00
| null |
XEROX NAMES NICOLE TORRACO AS SENIOR VICE PRESIDENT, CHIEF STRATEGY AND M&A OFFICER.
|
XEROX NAMES NICOLE TORRACO AS SENIOR VICE PRESIDENT, CHIEF STRATEGY AND M&A OFFICER
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-01-28 10:30:00
| null |
XEROX EXCEEDS Q4 EPS GUIDANCE, DELIVERS STRONG CASH FLOW AND OPERATING MARGIN.SEES FY 2020 ADJUSTED EARNINGS PER SHARE $3.60 TO $3.70.SEES FY 2020 GAAP EARNINGS PER SHARE $2.80 TO $2.90 FROM CONTINUING OPERATIONS.SEES 2020 OPERATING CASH FLOW FROM CONTINUING OPERATIONS OF ABOUT $1.3 BILLION & FREE CASH FLOW OF ABOUT $1.2 BILLION.QTRLY REVENUE $2.44 BILLION VERSUS ABOUT $2.5 BILLION.SEES 2020 REVENUE DECLINE OF ABOUT 4% AT CONSTANT CURRENCY, EXCLUDING REVENUE FROM $77 MILLION OEM LICENSE IN 2019.SEES AT LEAST $300 MILLION OF SHARE REPURCHASES & RETURN OF AT LEAST 50 PERCENT OF ANNUAL FREE CASH FLOW TO SHAREHOLDERS IN 2020.QTRLY GAAP EPS $1.17.QTRLY ADJUSTED EPS $1.33.Q4 EARNINGS PER SHARE VIEW $1.11, REVENUE VIEW $2.41 BILLION -- REFINITIV IBES DATA.FY2020 EARNINGS PER SHARE VIEW $3.51 -- REFINITIV IBES DATA.2020 GUIDANCE CONSISTENT WITH THREE-YEAR PLAN.
|
XEROX SEES FY 2020 ADJ. EARNINGS PER SHARE BETWEEN $3.60 TO $3.70
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-01-23 13:30:00
| null |
HP INC COMMENTS ON XEROX'S DIRECTOR NOMINATIONS TO HP BOARD; SAYS "NOMINATIONS ARE A SELF-SERVING TACTIC BY XEROX TO ADVANCE ITS PROPOSAL".
|
HP INC COMMENTS ON XEROX'S DIRECTOR NOMINATIONS TO HP BOARD
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-01-23 12:30:00
| null |
XEROX TO NOMINATE FULL SLATE OF DIRECTORS FOR ELECTION AT HP’S 2020 ANNUAL MEETING.XEROX HOLDINGS CORP - DIRECTOR NOMINEES TO HP BOARD INCLUDE BETSY ATKINS, GEORGE BICKERSTAFF, CAROLYN BYRD, JEANNIE DIEFENDERFER.XEROX HOLDINGS CORP - PROVIDED NOTICE TO HP INC THAT IT INTENDS TO NOMINATE 11 INDEPENDENT CANDIDATES TO REPLACE HP'S BOARD OF DIRECTORS.XEROX HOLDINGS - "WE BELIEVE HP SHAREHOLDERS WILL BE BETTER SERVED BY A NEW SLATE OF INDEPENDENT DIRECTORS".XEROX HOLDINGS CORP - DIRECTOR NOMINEES TO HP BOARD INCLUDE KIM FENNEBRESQUE , CAROL FLATON MATTHEW HART, FRED HOCHBERG, JACOB KATZ.XEROX HOLDINGS CORP - DIRECTOR NOMINEES TO HP BOARD INCLUDE NICHELLE MAYNARD-ELLIOTT, THOMAS SABATINO, JR..
|
XEROX TO NOMINATE FULL SLATE OF DIRECTORS FOR ELECTION AT HP'S 2020 ANNUAL MEETING
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-01-22 01:30:00
| null |
:XEROX TO NOMINATE AS MANY AS 11 DIRECTORS TO HP BOARD
|
XEROX TO NOMINATE AS MANY AS 11 DIRECTORS TO HP BOARD - WSJ
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-01-08 22:30:00
| null |
HP SENDS LETTER TO XEROX.HP - XEROX'S JAN 6 LETTER REGARDING FINANCING DOES NOT ADDRESS KEY ISSUE THAT XEROX'S PROPOSAL "SIGNIFICANTLY UNDERVALUES" HP.
|
HP SAYS XEROX'S JAN 6 LETTER DOES NOT ADDRESS KEY ISSUE THAT XEROX'S PROPOSAL "SIGNIFICANTLY UNDERVALUES" HP
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-01-06 11:30:00
| null |
XEROX SECURES $24 BILLION IN BINDING FINANCING COMMITMENTS FOR HP ACQUISITION.XEROX HOLDINGS - OBTAINED $24 BILLION IN BINDING FINANCING COMMITMENTS FROM CITI, MIZUHO AND BANK OF AMERICA TO COMPLETE COMBINATION WITH HP.XEROX CEO SAYS OFFER STANDS TO MEET WITH HP INC'S CHIP AND ENRIQUE IN PERSON, WITH OR WITHOUT THEIR ADVISORS, TO BEGIN NEGOTIATING TRANSACTION.XEROX CEO SAYS OVER LAST SEVERAL WEEKS, ENGAGED IN "CONSTRUCTIVE DIALOGUE" WITH MANY OF HP'S LARGEST SHAREHOLDERS REGARDING PROPOSED DEAL'S BENEFITS.
|
XEROX SECURES $24 BILLION IN BINDING FINANCING COMMITMENTS FOR HP ACQUISITION
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-01-05 20:30:00
| null |
FUJI XEROX TO END TECHNOLOGY AGREEMENT WITH XEROX CORPORATION ON SCHEDULED EXPIRATION DATE.FUJI XEROX CO- DECIDED TO END TECHNOLOGY AGREEMENT WITH XEROX CORP ON AGREEMENT'S EXPIRATION DATE, MARCH 31, 2021.FUJI XEROX SAYS WILL CONTINUE TO SUPPLY PRODUCTS TO XEROX CORPORATION AFTER TECHNOLOGY AGREEMENT ENDS.FUJI XEROX SAYS TECHNOLOGY AGREEMENT PROVIDES FOR TECHNOLOGY/BRAND LICENSES AND SALES TERRITORIES APPLICABLE TO EACH COMPANY..
|
FUJI XEROX SAYS TO END TECHNOLOGY AGREEMENT WITH XEROX CORP ON SCHEDULED EXPIRATION DATE
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-12-04 12:30:00
| null |
CARL C. ICAHN ISSUES OPEN LETTER TO HP INC. SHAREHOLDERS.CARL ICAHN - BELIEVE FIRMLY IN THE INDUSTRIAL LOGIC OF COMBINING HP INC AND XEROX HOLDINGS.CARL ICAHN - SEE NO OTHER PLAUSIBLE EXPLANATION FOR HP TO REFUSE TO ENGAGE IN CUSTOMARY MUTUAL DUE DILIGENCE.CARL ICAHN - WONDER WHETHER THIS IS SIMPLY DELAY TACTIC BY HP AIMED AT ATTEMPTING TO PRESERVE LUCRATIVE POSITIONS OF CEO AND MEMBERS OF THE BOARD.CARL ICHAN-FIRMLY BELIEVE HP SHAREHOLDERS DESERVE TO DECIDE WHETHER COMBINATION WITH XEROX MAKES SENSE BEFORE THE IDEA IS REJECTED BY CO’S BOARD.CARL ICAHN -IMPLORE HP SHAREHOLDERS WHO AGREE, TO REACH OUT TO HP’S DIRECTORS TO LET THEM KNOW, WHILE THERE IS WILLING COUNTERPARTY ON THE OTHER SIDE.
|
CARL ICAHN SAYS BELIEVE FIRMLY IN INDUSTRIAL LOGIC OF COMBINING HP INC AND XEROX HOLDINGS
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-12-03 23:30:00
| null |
:CARL ICAHN IS URGING HP TO PUSH AHEAD WITH TAKEOVER TALKS WITH XEROX
|
CARL ICAHN IS URGING HP TO PUSH AHEAD WITH TAKEOVER TALKS WITH XEROX- BLOOMBERG REPORTER ON TWITTER
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2019-12-03 10:30:00
| null |
XEROX HOLDINGS CORP SEES 2019 ADJUSTED EPS OF ABOUT $3.30 - $3.40 POST FUJIFILM TRANSACTIONS.XEROX HOLDINGS CORP SEES 2019 REVENUE AT CC DOWN ABOUT 5% POST FUJIFILM TRANSACTIONS.XEROX HOLDINGS CORP SEES 2019 FREE CASH FLOW OF ABOUT $1.1 BILLION - $1.2 BILLION POST FUJIFILM TRANSACTIONS.XEROX HOLDINGS CORP - SEES 2019 GAAP EPS OF ABOUT $2.50 - $2.60 POST FUJIFILM TRANSACTIONS.
|
XEROX HOLDINGS CORP SEES 2019 ADJ EPS OF ABOUT $3.30 - $3.40 POST FUJIFILM TRANSACTIONS
|
XRX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-07-13 08:30:00
| null |
CLEVELAND, OH / ACCESSWIRE / JULY 13, 2023 / NOVACCESS GLOBAL INC. (OTCQB:XSNX), A BIOMEDICAL COMPANY DEVELOPING NOVEL IMMUNOTHERAPIES FOR BRAIN TUMOR PATIENTS, TODAY ANNOUNCED THAT ITS CHIEF EXECUTIVE OFFICER DR. DWAIN K. IRVIN WILL BE PARTICIPATING IN THE NATIONAL BRAIN TUMOR SOCIETY'S (NBTS) FIFTH ANNUAL GLIOBLASTOMA AWARENESS DAY ON JULY 19, 2023 IN SUPPORT OF THE FIGHT AGAINST ONE OF THE FASTEST GROWING AND AGGRESSIVE BRAIN TUMORS.
|
NOVACCESS GLOBAL TO PARTICIPATE IN NATIONAL BRAIN TUMOR SOCIETY'S ANNUAL GLIOBLASTOMA AWARENESS DAY
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-06-16 12:40:00
| null |
CLEVELAND, OH AND BANGKOK, THAILAND / ACCESSWIRE / JUNE 16, 2023 / NOVACCESS GLOBAL INC. (OTCQB:XSNX), A BIOMEDICAL COMPANY DEVELOPING NOVEL IMMUNOTHERAPIES FOR BRAIN TUMOR PATIENTS, TODAY ANNOUNCED A PARTNERSHIP WITH THAILAND-BASED CKN VENTURES LIMITED, A MULTIFACETED CLINICAL AND COMMERCIAL HEALTHCARE PLATFORM, TO EXPAND CLINICAL DATA SET ACCESS IN SOUTHEAST ASIA TO ENHANCE AND ACCELERATE PERSONALIZED THERAPEUTICS AND TREATMENT PROTOCOLS. THIS PARTNERSHIP SUPPORTS NOVACCESS GLOBAL'S NEW PRECISION MEDICINE DIVISION, LAUNCHED EARLIER THIS MONTH, TO DEVELOP THE MOST COMPREHENSIVE COLLECTION OF PERSONALIZED THERAPEUTICS AND TREATMENT PROTOCOLS USING ARTIFICIAL INTELLIGENCE (AI), BIG DATA AND PREDICTIVE TECHNOLOGIES.
|
NOVACCESS GLOBAL PARTNERS WITH CKN VENTURES TO EXPAND ITS NEW AI-DRIVEN PRECISION MEDICINE DIVISION
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-06-01 08:40:00
| null |
CLEVLAND, OH / ACCESSWIRE / JUNE 1, 2023 / NOVACCESS GLOBAL INC. (OTCQB:XSNX), A BIOMEDICAL COMPANY DEVELOPING NOVEL IMMUNOTHERAPIES FOR BRAIN TUMOR PATIENTS, TODAY ANNOUNCED THE FORMATION OF ITS PRECISION MEDICINE DIVISION TO ENABLE MORE ENHANCED AND ACCELERATED PERSONALIZED THERAPEUTICS AND TREATMENT PROTOCOLS. USING AI, BIG DATA AND PREDICTIVE TECHNOLOGIES TO POWER ITS NEW PRECISION MEDICINE DIVISION, NOVACCESS GLOBAL WILL SEARCH THROUGH LICENSED DATABASES TO IDENTIFY PATIENT DATA (PHENOTYPIC, CLINICAL AND GENOMIC) FOR ANALYSIS AS PART OF ITS OWN AND ITS CLIENTS THERAPEUTIC DRUG DEVELOPMENT AND ITS CLIENTS' THERAPEUTIC TREATMENT PURPOSES.
|
NOVACCESS GLOBAL LAUNCHES PRECISION MEDICINE DIVISION USING AI, BIG DATA AND PREDICTIVE TECHNOLOGIES TO ACCELERATE PERSONALIZED HEALTHCARE THERAPIES
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-05-11 09:00:00
| null |
REPORT DETAILS PROMISE OF ADAPTIVE CANCER IMMUNOTHERAPY IN TREATING HIGHLY MALIGNANT BRAIN TUMORS RECENT ACHIEVEMENTS FOR GLIOBLASTOMA/BRAIN TUMOR TREATMENT TO BE ADDRESSED IN UPCOMING PRESENTATION AT WORLD ORPHAN DRUG CONGRESS CLEVELAND, OH / ACCESSWIRE / MAY 11, 2023 / NOVACCESS GLOBAL INC. (OTCQB:XSNX), A BIOMEDICAL COMPANY DEVELOPING NOVEL IMMUNOTHERAPIES FOR BRAIN TUMOR PATIENTS, TODAY ANNOUNCED THAT DR. CHRISTOPHER WHEELER, PH.D., PRESIDENT, STEMVAX THERAPEUTICS INC., A DIVISION OF NOVACCESS GLOBAL AND THE LEAD SCIENTIST FOR THE COMPANY, HAS BEEN PUBLISHED ALONG WITH OTHER RESEARCH PROFESSIONALS IN ONCOGENE , ONE OF THE WORLD'S LEADING CANCER JOURNALS.
|
NOVACCESS GLOBAL LEAD SCIENTIST PUBLISHED IN HIGH-PROFILE MEDICAL JOURNAL FOR CANCER VACCINE ADVANCEMENTS
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-03-15 09:00:00
| null |
DR. CHRISTOPHER WHEELER, NOVACCESS LEAD SCIENTIST, RECEIVES PRESTIGIOUS GOLDEN AXON AWARD CLEVELAND, OH / ACCESSWIRE / MARCH 15, 2023 / NOVACCESS GLOBAL INC. (OTCQB:XSNX), A BIOMEDICAL COMPANY DEVELOPING NOVEL IMMUNOTHERAPIES FOR BRAIN TUMOR PATIENTS, ANNOUNCED THAT DR. CHRISTOPHER WHEELER, PH.D., PRESIDENT, STEMVAX THERAPEUTICS INC., A DIVISION OF NOVACCESS GLOBAL AND THE LEAD SCIENTIST FOR THE COMPANY, RECEIVED THE PRESTIGIOUS GOLDEN AXON AWARD AT THE WORLD BRAIN MAPPING FOUNDATION (WBMF) ANNUAL CONGRESS, HELD ON FEBRUARY 17, 2023, IN LOS ANGELES, CA.
|
DR. CHRISTOPHER WHEELER, NOVACCESS LEAD SCIENTIST, RECEIVES PRESTIGIOUS GOLDEN AXON AWARD
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2023-01-05 12:15:00
| null |
TOPIC: IMMUNOTHERAPY ADVANTAGES OVER SURGICAL TREATMENT CLEVELAND, OH / ACCESSWIRE / JANUARY 5, 2023 / NOVACCESS GLOBAL INC. (OTCQB:XSNX), A BIOMEDICAL COMPANY DEVELOPING NOVEL IMMUNOTHERAPIES FOR BRAIN TUMOR PATIENTS, TODAY ANNOUNCED THE AVAILABILITY OF ITS LATEST MONTHLY INSTALLMENT IN A SERIES OF FIRESIDE CHAT INTERVIEWS, WITH ADDITIONAL SESSIONS TO BE MADE AVAILABLE AS COMPANY DEVELOPMENTS ARISE. INTERVIEWS ARE INTENDED TO COVER IMPORTANT AND TIMELY TOPICS RELATING TO THE COMPANY, ITS PLATFORM TECHNOLOGIES AND THE GLOBAL HEALTHCARE AND BUSINESS ENVIRONMENTS.
|
NOVACCESS GLOBAL ANNOUNCES FIRESIDE CHAT WITH DR. CHRISTOPHER WHEELER, THE COMPANY'S LEAD SCIENTIST AND PRESIDENT OF ITS STEMVAX THERAPEUTICS DIVISION
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-11-22 08:00:00
| null |
TOPIC: BENEFITS OF IMMUNOTHERAPIES VERSUS CONVENTIONAL CHEMOTHERAPY FOR PATIENTS AND THEIR SUPPORT NETWORKS CLEVELAND, OH / ACCESSWIRE / NOVEMBER 22, 2022 / NOVACCESS GLOBAL INC. (OTCQB:XSNX), A BIOMEDICAL COMPANY DEVELOPING NOVEL IMMUNOTHERAPIES FOR BRAIN TUMOR PATIENTS, TODAY ANNOUNCED THE AVAILABILITY OF ITS LATEST MONTHLY INSTALLMENT IN A SERIES OF FIRESIDE CHAT INTERVIEWS, WITH ADDITIONAL SESSIONS TO BE MADE AVAILABLE AS COMPANY DEVELOPMENTS ARISE. INTERVIEWS ARE INTENDED TO COVER IMPORTANT AND TIMELY TOPICS RELATING TO THE COMPANY, ITS PLATFORM TECHNOLOGIES AND THE GLOBAL HEALTHCARE AND BUSINESS ENVIRONMENTS.
|
NOVACCESS GLOBAL ANNOUNCES INITIAL FIRESIDE CHAT WITH GLIOBLASTOMA PATIENT ADVOCATE
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-11-10 14:00:00
| null |
CLEVELAND, OH / ACCESSWIRE / NOVEMBER 10, 2022 / NOVACCESS GLOBAL INC. (OTCQB:XSNX), A BIOMEDICAL COMPANY DEVELOPING NOVEL IMMUNOTHERAPIES FOR BRAIN TUMOR PATIENTS, TODAY ANNOUNCED THE APPOINTMENT OF PETER WEINSTEIN, PH.D., JD TO ITS SCIENTIFIC ADVISORY BOARD.
|
NOVACCESS GLOBAL APPOINTS HEALTHCARE IP CONSULTANT DR. PETER WEINSTEIN TO SCIENTIFIC ADVISORY BOARD
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-10-26 07:00:00
| null |
NOVACCESS GLOBAL RECEIVES FDA APPROVAL OF ORPHAN DRUG APPLICATION FOR TLR-AD1 FDA EXPANDS THE SCOPE OF THE COMPANY'S SUBMISSION ACCELERATES PATH TOWARD IMMUNOTHERAPY FOR GLIOBLASTOMA (BRAIN CANCER) CLEVELAND, OH / ACCESSWIRE / OCTOBER 26, 2022 / NOVACCESS GLOBAL INC. (OTCQB:XSNX), A BIOMEDICAL COMPANY DEVELOPING NOVEL IMMUNOTHERAPIES FOR BRAIN TUMOR PATIENTS, TODAY ANNOUNCED THE APPROVAL OF ITS APPLICATION WITH THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) FOR ORPHAN DRUG DESIGNATION (ODD) FOR TLR-AD1, A VACCINE IMMUNOTHERAPY FOR THE TREATMENT OF AGGRESSIVE BRAIN CANCERS, INCLUDING GLIOBLASTOMA AND OTHER HIGH-GRADE GLIOMAS. "ORPHAN DRUG DESIGNATION IS YET ANOTHER TIMELY MILESTONE ACHIEVED BY NOVACCESS GLOBAL AS WE PREPARE AN INVESTIGATIVE NEW DRUG (IND) APPLICATION FOR FDA APPROVAL TO START HUMAN CLINICAL TRIALS.
|
NOVACCESS GLOBAL RECEIVES FDA APPROVAL OF ORPHAN DRUG APPLICATION FOR TLR-AD1
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-10-20 09:17:00
| null |
TOPIC: OPPORTUNITIES FOR THE BIOMEDICAL FIELD AND FOR SHAREHOLDERS CLEVELAND, OH / ACCESSWIRE / OCTOBER 20, 2022 / NOVACCESS GLOBAL INC. (OTCQB:XSNX), A BIOMEDICAL COMPANY DEVELOPING NOVEL IMMUNOTHERAPIES FOR BRAIN TUMOR PATIENTS, TODAY ANNOUNCED THE AVAILABILITY OF ITS INITIAL INSTALLMENT IN A SERIES OF INTERVIEWS WITH ITS CORPORATE LEADERSHIP ON A MONTHLY BASIS FOR THE NEXT FOUR MONTHS, WITH ADDITIONAL SESSIONS TO BE MADE AVAILABLE AS COMPANY DEVELOPMENTS ARISE. INTERVIEWS ARE INTENDED TO COVER IMPORTANT AND TIMELY TOPICS RELATING TO THE COMPANY, ITS PLATFORM TECHNOLOGIES AND THE GLOBAL HEALTHCARE AND BUSINESS ENVIRONMENTS.
|
NOVACCESS GLOBAL ANNOUNCES FIRESIDE CHAT WITH BOARD MEMBER PERSPECTIVES
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-09-22 09:00:00
| null |
INCLUDES 7.5 MILLION SHARES FOR INNOVEST GLOBAL SHARE DISTRIBUTION INCREASES UNAFFILIATED FLOAT WHILE SIGNIFICANTLY EXPANDING SHAREHOLDER BASE CLEVELAND, OH / ACCESSWIRE / SEPTEMBER 22, 2022 / NOVACCESS GLOBAL INC. (OTCQB:XSNX), A BIOMEDICAL COMPANY DEVELOPING NOVEL IMMUNOTHERAPIES FOR BRAIN TUMOR PATIENTS, TODAY ANNOUNCED THAT THE SECURITIES AND EXCHANGE COMMISSION ("SEC") HAS DECLARED THE COMPANY'S REGISTRATION STATEMENT ON FORM S-1 EFFECTIVE AS OF SEPTEMBER 16, 2022. NOVACCESS GLOBAL'S CHIEF EXECUTIVE OFFICER DR. DWAIN K.
|
NOVACCESS GLOBAL ANNOUNCES EFFECTIVENESS OF FORM S-1 REGISTRATION STATEMENT
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-08-10 09:00:00
| null |
CLEVELAND, OH / ACCESSWIRE / AUGUST 10, 2022 / NOVACCESS GLOBAL INC. (OTCQB:XSNX), A BIOMEDICAL COMPANY DEVELOPING NOVEL IMMUNOTHERAPIES FOR BRAIN TUMOR PATIENTS, TODAY ANNOUNCED THAT THE TRADING OF ITS COMMON SHARES HAS BEEN UPGRADED TO THE OTC MARKETS GROUP'S OTCQB® PLATFORM FROM THE OTC PINK MARKET. THE COMPANY'S TICKER SYMBOL REMAINS THE SAME.
|
NOVACCESS GLOBAL ANNOUNCES UPLISTING TO OTCQB
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-07-19 12:15:00
| null |
THIS CORRECTS THE RELEASE THAT RAN EARLIER TODAY, REPLACING THE NAME OF THE EXECUTIVE QUOTED IN THE PRESS RELEASE AND OTHER MINOR EDITS. ACCELERATING ON THE PATH TOWARD IMMUNOTHERAPY FOR GLIOBLASTOMA (BRAIN CANCER) CLEVELAND, OH / ACCESSWIRE / JULY 19, 2022 / NOVACCESS GLOBAL INC. (OTC PINK:XSNX), A BIOMEDICAL COMPANY DEVELOPING NOVEL IMMUNOTHERAPIES FOR BRAIN TUMOR PATIENTS, TODAY ANNOUNCED THE FILING OF AN APPLICATION WITH THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) TO RECEIVE ORPHAN DRUG DESIGNATION (ODD) FOR TLR-AD1, A VACCINE IMMUNOTHERAPY FOR THE TREATMENT OF AGGRESSIVE BRAIN CANCERS, INCLUDING GLIOBLASTOMA AND OTHER HIGH GRADE GLIOMAS.
|
CORRECTION: NOVACCESS GLOBAL ANNOUNCES FILING OF ORPHAN DRUG APPLICATION FOR TLR-AD1
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-07-19 09:00:00
| null |
ACCELERATING ON THE PATH TOWARD IMMUNOTHERAPY FOR GLIOBLASTOMA (BRAIN CANCER) CLEVELAND, OH / ACCESSWIRE / JULY 19, 2022 / NOVACCESS GLOBAL INC. (OTC PINK:XSNX), A BIOMEDICAL COMPANY DEVELOPING NOVEL IMMUNOTHERAPIES FOR BRAIN TUMOR PATIENTS, TODAY ANNOUNCED THE FILING OF AN APPLICATION WITH THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) TO RECEIVE ORPHAN DRUG DESIGNATION (ODD) FOR TLR-AD1, A VACCINE IMMUNOTHERAPY FOR THE TREATMENT OF AGGRESSIVE BRAIN CANCERS, INCLUDING GLIOBLASTOMA MULTIFORME (GBM) AND OTHER HIGH GRADE GLIOMAS. GBM IS A FORM OF AGGRESSIVE BRAIN CANCER THAT ANNUALLY IMPACTS APPROXIMATELY 250,000 PEOPLE GLOBALLY AND IS ON THE RISE IN MANY COUNTRIES, ACCORDING TO NOVACCESS SCIENTISTS AND PUBLISHED REPORTS.
|
NOVACCESS GLOBAL ANNOUNCES FILING OF ORPHAN DRUG APPLICATION FOR TLR-AD1
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-06-14 14:05:00
| null |
CLEVELAND, OH / ACCESSWIRE / JUNE 14, 2022 / NOVACCESS GLOBAL INC. (OTC PINK:XSNX) ANNOUNCED THAT ITS CHIEF EXECUTIVE OFFICER DR. DWAIN IRVIN WAS A FEATURED GUEST ON MONEYTV, AN INTERNATIONALLY-SYNDICATED WEEKLY BUSINESS TELEVISION PROGRAM REACHING MORE THAN 180 MILLION TV HOUSEHOLDS GLOBALLY AND HOSTED BY VETERAN INVESTMENT JOURNALIST DONALD BAILLARGEON. THE SHOW WILL BE BROADCAST ON TV WITH VIEWING AVAILABLE BY ACCESSING THE FOLLOWING LINK: HTTP://MONEYTV.NET/GLOBAL-TV-LISTING/.
|
NOVACCESS GLOBAL CEO DWAIN IRVIN FEATURED ON MONEYTV
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-06-10 05:00:00
| null |
HOLLYWOOD, CA / ACCESSWIRE / JUNE 10, 2022 / CANCER TREATMENT, METAVERSE, COPING; THIS WEEK ON MONEYTV WITH DONALD BAILLARGEON MONEYTV IS THE INTERNATIONALLY SYNDICATED TELEVISION PROGRAM ALL ABOUT MONEY AND WHAT MAKES IT HAPPEN, (HTTP://WWW.MONEYTV.NET), FEATURING INFORMATIVE INTERVIEWS WITH COMPANY CEOS AND EXECUTIVES, PROVIDING INSIGHTS INTO THEIR OPERATIONS AND OUTLOOKS FOR THEIR FUTURES. MONEYTV IS SEEN IN OVER 200 MILLION TV HOUSEHOLDS IN MORE THAN 75 COUNTRIES.
|
THIS WEEK ON MONEYTV WITH DONALD BAILLARGEON, 6/10
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-17 12:00:00
| null |
LOS ANGELES, CA / ACCESSWIRE / MARCH 17, 2022 / NOVACCESS GLOBAL INC. (OTC PINK:XSNX) ANNOUNCED TODAY THE CLOSING OF A SERIES OF TRANSACTIONS WHICH RESULTS IN THE REDUCTION OF POTENTIAL COMMON STOCK DILUTION BY 97.6% AND EXPANSION OF THE SHAREHOLDER BASE. THE TRANSACTIONS ANNOUNCED TODAY ARE MORE COMPLETELY DESCRIBED IN THE COMPANY'S FORM 8-K FILED ON MARCH 14, 2022, WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION.
|
NOVACCESS GLOBAL STOCK REDEMPTION AND EXPANDED BOARD OF DIRECTORS REINFORCES SHAREHOLDER VALUE AND POSITIONS THE COMPANY TO ACCELERATE OBJECTIVES
|
XSNX
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-09-21 08:00:00
| null |
NEW SUITE OF CURATED PRODUCTS FOR WOMEN ARE CLEAN, SUSTAINABLE AND PRIMARILY SOURCED FROM WOMEN-OWNED COMPANIES NEW SUITE OF CURATED PRODUCTS FOR WOMEN ARE CLEAN, SUSTAINABLE AND PRIMARILY SOURCED FROM WOMEN-OWNED COMPANIES
|
XPRESSPA GROUP EXPANDS RETAIL PRODUCTS FOR WOMEN, UNDERSCORING COMPANY'S COMMITMENT TO SUPPORT WOMEN'S HEALTH AND WELLNESS
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-08-15 09:00:00
| null |
PUBLIC-PRIVATE PARTNERSHIP TO ENABLE THE DEVELOPMENT OF INNOVATIVE, SUSTAINABLE INFRASTRUCTURE DESIGNED TO SET THE GLOBAL STANDARD FOR TRAVEL BIOSECURITY PUBLIC-PRIVATE PARTNERSHIP TO ENABLE THE DEVELOPMENT OF INNOVATIVE, SUSTAINABLE INFRASTRUCTURE DESIGNED TO SET THE GLOBAL STANDARD FOR TRAVEL BIOSECURITY
|
GINKGO BIOWORKS AND XPRESCHECK RECEIVE AWARD TO EXPAND CDC'S TRAVELER-BASED SARS-COV-2 GENOMIC SURVEILLANCE PROGRAM IN U.S. AIRPORTS
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-08-15 08:49:00
| null |
PUBLIC-PRIVATE PARTNERSHIP TO ENABLE THE DEVELOPMENT OF INNOVATIVE, SUSTAINABLE INFRASTRUCTURE DESIGNED TO SET THE GLOBAL STANDARD FOR TRAVEL BIOSECURITY BOSTON AND NEW YORK , AUG. 15, 2022 /PRNEWSWIRE/ -- GINKGO BIOWORKS (NYSE: DNA) AND XPRESSPA GROUP, INC. (NASDAQ: XSPA) ANNOUNCED THEY WILL CONTINUE TO SUPPORT THE CENTERS FOR DISEASE CONTROL AND PREVENTION'S (CDC'S) TRAVELER-BASED SARS-COV-2 GENOMIC SURVEILLANCE PROGRAM THROUGH A NEW CONTRACT AWARDED AUGUST 12, 2022. THE PARTNERSHIP IS EXPECTED TO SUPPORT PUBLIC HEALTH AND BIOSECURITY SERVICES TOTALING APPROXIMATELY $16 MILLION, WITH AN OVERALL POTENTIAL TO EXCEED $61 MILLION BASED ON CDC PROGRAM OPTIONS AND PUBLIC HEALTH PRIORITIES.
|
GINKGO BIOWORKS AND XPRESCHECK RECEIVE AWARD TO EXPAND CDC'S TRAVELER-BASED SARS-COV-2 GENOMIC SURVEILLANCE PROGRAM IN U.S. AIRPORTS
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-08-12 08:00:00
| null |
RESURGENCE OF TRAVEL SEES SURGE IN DEMAND OF AIRPORT SELF-CARE SOLUTIONS AND AMENITIES FOR PASSENGERS RESURGENCE OF TRAVEL SEES SURGE IN DEMAND OF AIRPORT SELF-CARE SOLUTIONS AND AMENITIES FOR PASSENGERS
|
XPRESSPA GROUP ANNOUNCES THE RE-OPENING OF XPRESSPA™ LOCATION AT JOHN F. KENNEDY INTERNATIONAL AIRPORT'S TERMINAL 4
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-07-11 13:30:00
| null |
NEW YORK, JULY 11, 2022 (GLOBE NEWSWIRE) -- XPRESSPA GROUP, INC. (NASDAQ: XSPA), A TRAVEL HEALTH AND WELLNESS COMPANY, ANNOUNCED IT IS EXPANDING ITS OPERATIONS OUTSIDE THE UNITED STATES WITH THE OPENING OF XPRESSPA LOCATIONS AT ISTANBUL AIRPORT IN TURKEY BEGINNING SEPTEMBER 2022. THIS IS THE FIRST OF FIVE NEW XPRESSPA LOCATIONS EXPECTED TO OPEN AT ISTANBUL AIRPORT.
|
XPRESSPA GROUP ANNOUNCES PLAN FOR EXPANSION INTERNATIONALLY
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-06-14 16:05:00
| null |
OMAR HAYNES NAMED INTERIM CHIEF FINANCIAL OFFICER OMAR HAYNES NAMED INTERIM CHIEF FINANCIAL OFFICER
|
XPRESSPA GROUP ANNOUNCES THE SEPARATION OF SERVICE OF CHIEF FINANCIAL OFFICER JAMES BERRY
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-05-20 09:00:00
| null |
NEW YORK, MAY 20, 2022 (GLOBE NEWSWIRE) -- XPRESSPA GROUP, INC. (NASDAQ: XSPA), A TRAVEL HEALTH AND WELLNESS COMPANY, TODAY ANNOUNCED THAT ITS BOARD OF DIRECTORS HAS AUTHORIZED A 10 MILLION SHARE INCREASE TO ITS EXISTING STOCK REPURCHASE PROGRAM AND TO EXTEND IT THROUGH SEPTEMBER 15, 2023.
|
XPRESSPA GROUP, INC. ANNOUNCES 10 MILLION SHARE INCREASE IN STOCK REPURCHASE PROGRAM
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-04-18 16:05:00
| null |
THE ONE-STOP TRAVEL, HEALTH, AND WELLNESS PROVIDER IS TRANSFORMING CARE ACCESS THROUGH A SUITE OF INTEGRATED SERVICES FOR PEOPLE ON THE GO THE ONE-STOP TRAVEL, HEALTH, AND WELLNESS PROVIDER IS TRANSFORMING CARE ACCESS THROUGH A SUITE OF INTEGRATED SERVICES FOR PEOPLE ON THE GO
|
XPRESSPA GROUP'S TRAVEL HEALTH AND WELLNESS BRAND TREAT™ LAUNCHES AT PHOENIX SKY HARBOR INTERNATIONAL AIRPORT
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-30 08:00:00
| null |
LOCATED PRE-SECURITY IN THE SOUTH WALK AREA OF THE MAIN TERMINAL LOCATED PRE-SECURITY IN THE SOUTH WALK AREA OF THE MAIN TERMINAL
|
XPRESCHECK® OPENS COVID-19 TESTING FACILITY AT ORLANDO INTERNATIONAL AIRPORT
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-28 08:30:00
| null |
THIS SUMMER, THE COMPANY WILL EXPAND ITS INTERNATIONAL PRESENCE AND OFFER SELECT TRAVEL RETAIL AND WELLNESS SERVICES AT NEW ISTANBUL AIRPORT THIS SUMMER, THE COMPANY WILL EXPAND ITS INTERNATIONAL PRESENCE AND OFFER SELECT TRAVEL RETAIL AND WELLNESS SERVICES AT NEW ISTANBUL AIRPORT
|
XPRESSPA GROUP ANNOUNCES THE ADDITION OF FIVE NEW XPRESSPA LOCATIONS IN ISTANBUL
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-03-15 16:05:00
| null |
STRONGEST FINANCIAL RESULTS IN COMPANY HISTORY MARKS END TO BANNER YEAR
|
XPRESSPA GROUP REPORTS RECORD FULL YEAR 2021 RESULTS
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-31 09:00:00
| null |
SARS-COV-2 VARIANT IDENTIFICATION PROGRAM EXPANDS BEYOND INITIAL PILOT; NOW TOTALS $5.6 MILLION SARS-COV-2 VARIANT IDENTIFICATION PROGRAM EXPANDS BEYOND INITIAL PILOT; NOW TOTALS $5.6 MILLION
|
XPRESSPA GROUP EXTENDS COLLABORATION WITH CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) TO CONDUCT ONGOING COVID-19 BIOSURVEILLANCE AT U.S. AIRPORTS
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-21 09:00:00
| null |
NEW YORK, JAN. 21, 2022 (GLOBE NEWSWIRE) -- XPRESSPA GROUP, INC. (NASDAQ: XSPA), A TRAVEL HEALTH AND WELLNESS COMPANY, TODAY ANNOUNCED THAT ITS BOARD OF DIRECTORS HAS NAMED CURRENT CHIEF OPERATING OFFICER SCOTT R. MILFORD TO THE ROLE OF PRESIDENT AND CHIEF EXECUTIVE OFFICER. THIS APPOINTMENT IS EFFECTIVE JANUARY 19, 2022, AND FOLLOWS THE RESIGNATION OF DOUG SATZMAN FOR PERSONAL REASONS.
|
XPRESSPA GROUP NAMES SCOTT R. MILFORD AS PRESIDENT AND CHIEF EXECUTIVE OFFICER
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-10 09:10:00
| null |
NEW YORK, JAN. 10, 2022 (GLOBE NEWSWIRE) -- XPRESSPA GROUP, INC. (NASDAQ: XSPA), A TRAVEL HEALTH AND WELLNESS COMPANY, TODAY ANNOUNCED THAT A MAJORITY OF THE INDEPENDENT MEMBERS OF ITS BOARD OF DIRECTORS GRANTED AN EQUITY AWARD TO EZRA T. ERNST, WHO WAS PREVIOUSLY AFFILIATED WITH GCG CONNECT LLC D/B/A HYPERPOINTE (“HYPERPOINTE”) AND WHO WAS OFFERED EMPLOYMENT WITH THE COMPANY IN CONNECTION WITH XPRESSPA'S ACQUISITION OF THE EQUITY INTERESTS OF HYPERPOINTE, AS AN INDUCEMENT MATERIAL TO SUCH NEW EMPLOYEE ENTERING INTO EMPLOYMENT WITH THE COMPANY. THE EQUITY AWARD WAS APPROVED ON JANUARY 7, 2022, IN ACCORDANCE WITH NASDAQ LISTING RULE 5635(C)(4).
|
XPRESSPA GROUP ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-10 09:00:00
| null |
XPRESCHECK® EXPANDING DIGITAL HEALTH CAPABILITIES & DATA ANALYTICS SERVICES XPRESCHECK® EXPANDING DIGITAL HEALTH CAPABILITIES & DATA ANALYTICS SERVICES
|
XPRESSPA GROUP ANNOUNCES STRATEGIC ACQUISITION OF HYPERPOINTE
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2022-01-10 08:30:00
| null |
PARTICIPATING IN THE VIRTUAL H.C. WAINWRIGHT BIOCONNECT CONFERENCE ON JANUARY 10 TH – 13 TH
|
XPRESSPA GROUP REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2021 REVENUE
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-12-16 08:30:00
| null |
IN CONJUNCTION WITH TREAT'S MOBILE APP, THIS NEW LOCATION IS BOTH A FULLY OPERATIONAL UPSCALE HEALTH AND WELLNESS CARE CENTER WITH BOARD-CERTIFIED PHYSICIANS AND PROVIDES OTHER LUXURY WELLNESS SERVICES FOR TRAVELERS IN CONJUNCTION WITH TREAT'S MOBILE APP, THIS NEW LOCATION IS BOTH A FULLY OPERATIONAL UPSCALE HEALTH AND WELLNESS CARE CENTER WITH BOARD-CERTIFIED PHYSICIANS AND PROVIDES OTHER LUXURY WELLNESS SERVICES FOR TRAVELERS
|
XPRESSPA GROUP'S NEW TRAVEL HEALTH & WELLNESS BRAND TREAT™ LAUNCHES ITS FIRST BRICK AND MORTAR LOCATION NOW OPEN AT JOHN F. KENNEDY INTERNATIONAL AIRPORT'S TERMINAL 4
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-12-07 07:00:00
| null |
BOSTON, DEC. 7, 2021 /PRNEWSWIRE/ -- GINKGO BIOWORKS (NYSE: DNA) TODAY CONFIRMED THAT IT HAS COLLECTED, IDENTIFIED, AND SEQUENCED A POOLED SAMPLE CONTAINING THE OMICRON VARIANT FROM PASSENGERS ON FLIGHTS ORIGINATING FROM SOUTH AFRICA AND THE UNITED KINGDOM AND ARRIVING AT NEWARK INTERNATIONAL AIRPORT ON THE 30TH OF NOVEMBER AND THE 1ST OF DECEMBER. THESE SAMPLES WERE COLLECTED IN PARTNERSHIP WITH THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) AND XPRESSPA GROUP, INC. (NASDAQ: XSPA) IN THE COURSE OF SERVICING THEIR JOINT AIR TRAVEL COVID-19 MONITORING PROGRAM.
|
CONCENTRIC BY GINKGO CONFIRMS DETECTION OF OMICRON VARIANT THROUGH COVID-19 AIR TRAVEL BIOSECURITY COLLABORATION WITH CDC AND XPRESCHECK
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-12-06 08:30:00
| null |
DOUG SATZMAN, CEO OF XPRESSPA GROUP, TO DISCUSS THE FACTORS DRIVING THE XPRESCHECK BUSINESS OF XPRESSPA GROUP DOUG SATZMAN, CEO OF XPRESSPA GROUP, TO DISCUSS THE FACTORS DRIVING THE XPRESCHECK BUSINESS OF XPRESSPA GROUP
|
XPRESSPA GROUP ANNOUNCES PARTICIPATION IN THE WATER TOWER RESEARCH FIRESIDE CHAT SERIES
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-30 08:30:00
| null |
THE COMPANY HAS FINAL APPROVAL TO CONVERT LEGACY XPRESSPA IN CONCOURSE E TO XPRESCHECK THE COMPANY HAS FINAL APPROVAL TO CONVERT LEGACY XPRESSPA IN CONCOURSE E TO XPRESCHECK
|
XPRESCHECK™ TO OPEN COVID-19 TESTING FACILITY AT HARTSFIELD-JACKSON ATLANTA INTERNATIONAL AIRPORT
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-09-15 07:00:00
| null |
NEW YORK, SEPT. 15, 2021 (GLOBE NEWSWIRE) -- XPRESSPA GROUP, INC. (NASDAQ: XSPA) (“XPRESSPA” OR THE “COMPANY”), A HEALTH AND WELLNESS COMPANY, ANNOUNCED THAT THE COMPANY WILL PARTICIPATE AND HOST MEETINGS WITH INSTITUTIONAL INVESTORS AT THE JEFFERIES VIRTUAL FITNESS & WELLNESS SUMMIT TODAY.
|
XPRESSPA GROUP TO PARTICIPATE IN JEFFERIES VIRTUAL FITNESS & WELLNESS SUMMIT TODAY
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-16 16:10:00
| null |
RECORD MSA PRACTICE PATIENT FEES INCREASES TO $17.1 MILLION IN Q2 AGAINST $6.3 MILLION IN Q1
|
XPRESSPA GROUP ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-13 08:30:00
| null |
EIGHT-WEEK PILOT PROGRAM FOCUSES ON IDENTIFYING NEW SARS-COV-2 VARIANTS ENTERING THE U.S.
|
XPRESSPA GROUP™ RECEIVES APPROVAL FOR A $2 MILLION PROGRAM WITH THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR BIOSURVEILLANCE TRACKING IN COLLABORATION WITH CONCENTRIC BY GINKGO AT THREE MAJOR U.S. AIRPORTS
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-12 08:30:00
| null |
THE TREAT™ CARE APP WILL PROVIDE ON-DEMAND, VIRTUAL CARE SERVICES FOR TRAVELERS THE TREAT™ CARE APP WILL PROVIDE ON-DEMAND, VIRTUAL CARE SERVICES FOR TRAVELERS
|
XPRESSPA GROUP ANNOUNCES AGREEMENT WITH 98POINT6 AS THE TREAT™ PARTNER FOR VIRTUAL CARE
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-08-03 08:30:00
| null |
XPRESCHECK WILL PROVIDE ON-SITE TESTING FOR SELECT EL AL ISRAEL AIRLINES TRAVEL ROUTES IN TERMINAL 4 AT JOHN F. KENNEDY INTERNATIONAL AIRPORT XPRESCHECK WILL PROVIDE ON-SITE TESTING FOR SELECT EL AL ISRAEL AIRLINES TRAVEL ROUTES IN TERMINAL 4 AT JOHN F. KENNEDY INTERNATIONAL AIRPORT
|
XPRESSPA GROUP ANNOUNCES NEW PILOT PROGRAM IN COLLABORATION WITH EL AL ISRAEL AIRLINES FOR PRE-FLIGHT COVID-19 VARIANT TESTING THROUGH XPRESCHECK TESTING FACILITIES
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-07-30 09:26:00
| null |
XPRESSPA GROUP WILL BE MATCHING UP TO $100,000 DONATIONS FOR THE CAMPAIGN, WHICH ENABLES THE PURCHASE OF COVID-19 VACCINES FOR LOWER-INCOME COUNTRIES XPRESSPA GROUP WILL BE MATCHING UP TO $100,000 DONATIONS FOR THE CAMPAIGN, WHICH ENABLES THE PURCHASE OF COVID-19 VACCINES FOR LOWER-INCOME COUNTRIES
|
XPRESSPA GROUP ANNOUNCES COLLABORATION WITH THE “GO GIVE ONE” CAMPAIGN BY THE WORLD HEALTH ORGANIZATION FOUNDATION
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-07-29 16:30:00
| null |
WEBCAST AND CONFERENCE CALL SCHEDULED FOR 4:30 PM ET WEBCAST AND CONFERENCE CALL SCHEDULED FOR 4:30 PM ET
|
XPRESSPA GROUP TO PROVIDE BUSINESS UPDATE AND ANNOUNCE SECOND QUARTER 2021 FINANCIAL RESULTS ON AUGUST 16
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-06-28 08:30:00
| null |
PILOT PROGRAM AT FOUR TOP PERFORMING SPAS ADDITIONAL SPA REOPENINGS MAY FOLLOW LATER THIS SUMMER PILOT PROGRAM AT FOUR TOP PERFORMING SPAS ADDITIONAL SPA REOPENINGS MAY FOLLOW LATER THIS SUMMER
|
XPRESSPA GROUP ANNOUNCES THE RE-OPENING OF XPRESSPA™ LOCATIONS BY JULY 1
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-06-09 08:30:00
| null |
NEW YORK, JUNE 09, 2021 (GLOBE NEWSWIRE) -- XPRESSPA GROUP, INC. (NASDAQ: XSPA) (“XPRESSPA” OR THE “COMPANY”), A HEALTH AND WELLNESS COMPANY, TODAY ANNOUNCED THAT THE COMPANY IS SET TO JOIN THE RUSSELL MICROCAP® INDEX AT THE CONCLUSION OF THE 2021 RUSSELL INDEXES ANNUAL RECONSTITUTION ACCORDING TO A PRELIMINARY LIST OF ADDITIONS POSTED ON JUNE 4. JOINING THE INDEX WOULD BECOME EFFECTIVE AFTER THE US MARKET OPENS ON JUNE 28.
|
XPRESSPA GROUP SET TO JOIN RUSSELL MICROCAP® INDEX
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-06-01 08:30:00
| null |
TREAT™ AIMS TO CONNECT TRAVELERS WITH INTEGRATED CARE SERVICES SO THEY CAN EXPLORE THE WORLD WITH CONFIDENCE INITIAL WEBSITE AND BRAND CAMPAIGN LAUNCHING TODAY MOBILE APP LAUNCH (PHASE TWO) AND FIRST TWO LOCATIONS (PHASE THREE) EXPECTED TO OPEN LATE SUMMER / EARLY FALL
|
XPRESSPA GROUP ANNOUNCES THE LAUNCH OF TREATCARE.COM, PHASE ONE OF NEW TRAVEL, HEALTH AND WELLNESS LIFESTYLE BRAND
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-17 16:05:00
| null |
RECOGNIZES $8.2 MILLION OF REVENUE FROM XPRESCHECK™ IN THE FIRST QUARTER OF 2021, INCLUDING $3.2 MILLION RELATED TO 2020
|
XPRESSPA GROUP PROVIDES BUSINESS UPDATE AND ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-05-10 08:30:00
| null |
WEBCAST AND CONFERENCE CALL SCHEDULED FOR 4:30 PM ET WEBCAST AND CONFERENCE CALL SCHEDULED FOR 4:30 PM ET
|
XPRESSPA GROUP TO PROVIDE BUSINESS UPDATE AND ANNOUNCE FIRST QUARTER 2021 FINANCIAL RESULTS ON MAY 17
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-21 10:05:00
| null |
LOCATED PRE-SECURITY AT TERMINAL 3 LOCATED PRE-SECURITY AT TERMINAL 3
|
XPRESCHECK™ OPENS COVID-19 TESTING FACILITY AT SAN FRANCISCO INTERNATIONAL AIRPORT
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-07 08:30:00
| null |
PRE-SECURITY LOCATION PROVIDES ACCESS TO ALL PASSENGERS, REGARDLESS OF AIRLINE PRE-SECURITY LOCATION PROVIDES ACCESS TO ALL PASSENGERS, REGARDLESS OF AIRLINE
|
XPRESCHECK™ OPENS COVID-19 TESTING FACILITY AT SEATTLE-TACOMA INTERNATIONAL AIRPORT
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-04-06 08:30:00
| null |
TO BE LOCATED PRE-SECURITY AT TERMINAL 3 TO BE LOCATED PRE-SECURITY AT TERMINAL 3
|
XPRESSPA GROUP SIGNS CONTRACT FOR AN XPRESCHECK™ COVID-19 POP-UP TESTING FACILITY AT SAN FRANCISCO INTERNATIONAL AIRPORT
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-29 08:30:00
| null |
NEW YORK, MARCH 29, 2021 (GLOBE NEWSWIRE) -- XPRESSPA GROUP, INC. (NASDAQ: XSPA), A HEALTH AND WELLNESS COMPANY, WILL CONTINUE TO EXPAND ITS RAPID COVID-19 TESTING EFFORTS BY OFFERING TRAVELERS ANOTHER OPTION WITH A RAPID PCR-BASED TESTING PLATFORM. THE ADDITION WILL ENABLE XPRESCHECK™ TO INCREASE THE AVAILABILITY OF RAPID PCR–BASED COVID-19 TESTS AT XPRESCHECK AIRPORT SITES, STARTING WITH PILOTS AT JOHN F. KENNEDY INTERNATIONAL AIRPORT TODAY AND GEORGE BUSH INTERCONTINENTAL AIRPORT IN HOUSTON NEXT WEEK.
|
XPRESSPA GROUP ANNOUNCES RAPID PCR TESTING OPTION TO EXPEDITE COVID-19 TESTING RESULTS IN REAL TIME FOR MORE AIRLINE PASSENGERS
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-23 16:05:00
| null |
WEBCAST AND CONFERENCE CALL SCHEDULED FOR 4:30 PM ET WEBCAST AND CONFERENCE CALL SCHEDULED FOR 4:30 PM ET
|
XPRESSPA GROUP TO PROVIDE BUSINESS UPDATE AND ANNOUNCE FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS ON MARCH 31
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-15 08:30:00
| null |
PRE-SECURITY LOCATIONS ALLOW ACCESS TO ALL PASSENGERS, REGARDLESS OF AIRLINE PRE-SECURITY LOCATIONS ALLOW ACCESS TO ALL PASSENGERS, REGARDLESS OF AIRLINE
|
XPRESSPA GROUP AND METROPOLITAN WASHINGTON AIRPORTS AUTHORITY ANNOUNCE THE OPENING OF XPRESCHECK™ COVID-19 TESTING FACILITIES AT DULLES INTERNATIONAL AIRPORT AND REAGAN NATIONAL AIRPORT
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-03-08 08:30:00
| null |
LOCATED POST-SECURITY, TERMINAL E, OPERATED BY UNITED AIRLINES
|
XPRESSPA GROUP AND UNITED AIRLINES ANNOUNCE THE OPENING OF AN XPRESCHECK™ COVID-19 TESTING FACILITY AT HOUSTON GEORGE BUSH INTERCONTINENTAL AIRPORT
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-02-18 08:30:00
| null |
BOTH LOCATIONS EXPECTED TO COMMENCE OPERATIONS BY MID-MARCH BOTH LOCATIONS EXPECTED TO COMMENCE OPERATIONS BY MID-MARCH
|
XPRESSPA GROUP SIGNS CONTRACT WITH METROPOLITAN WASHINGTON AIRPORTS AUTHORITY FOR XPRESCHECK™ COVID-19 TESTING FACILITIES AT DULLES INTERNATIONAL AIRPORT AND REAGAN NATIONAL AIRPORT
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-01-28 08:30:00
| null |
XPRESCHECK TESTING FACILITIES SUPPORT NEW RAPID TESTING REQUIREMENTS FOR SELECT FLIGHTS WITH UNITED, DELTA AND KLM FROM JFK, NEWARK AND BOSTON AIRPORTS INTO THE NETHERLANDS
|
XPRESSPA GROUP SUPPORTS AIRLINES TO MEET DUTCH TRAVEL RESTRICTIONS; XPRESCHECK TO PILOT RAPID COVID-19 ANTIGEN TESTS FOR TRANSATLANTIC FLIGHTS
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2021-01-20 08:30:00
| null |
LOCATED WITHIN CONCOURSE A, POST SECURITY LOCATED WITHIN CONCOURSE A, POST SECURITY
|
XPRESCHECK™ COVID-19 TESTING FACILITY OPENS AT SALT LAKE CITY INTERNATIONAL AIRPORT TODAY
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-28 08:30:00
| null |
XPRESCHECK TESTING CENTERS WILL START OFFERING ON-SITE TESTING FROM SELECT CITIES FOR NON-STOP FLIGHTS TO HAWAI‘I XPRESCHECK TESTING CENTERS WILL START OFFERING ON-SITE TESTING FROM SELECT CITIES FOR NON-STOP FLIGHTS TO HAWAI‘I
|
XPRESSPA GROUP ANNOUNCES NEW AGREEMENT WITH HAWAIIAN AIRLINES AND THE STATE OF HAWAI‘I AS A TRUSTED PARTNER FOR COVID-19 TESTING WITH XPRESCHECK TESTING FACILITIES
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-22 08:30:00
| null |
EXPECTED TO COMMENCE OPERATIONS BY MID-JANUARY EXPECTED TO COMMENCE OPERATIONS BY MID-JANUARY
|
XPRESSPA GROUP HAS SIGNED A DEAL FOR A NEW XPRESCHECK™ COVID-19 TESTING FACILITY AT SALT LAKE CITY INTERNATIONAL AIRPORT
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-21 08:30:00
| null |
A SECOND XPRESCHECK TESTING LOCATION HAS STARTED CONSTRUCTION AT LOGAN INTERNATIONAL WITH PLANS TO OPEN IN EARLY JANUARY IN JETBLUE'S TERMINAL C
|
XPRESSPA GROUP ANNOUNCES NEW COLLABORATION WITH JETBLUE AIRLINES AT BOSTON LOGAN INTERNATIONAL AIRPORT FOR BOTH RAPID AND PCR COVID-19 TESTING
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-17 12:49:00
| null |
NEW YORK, DEC. 17, 2020 (GLOBE NEWSWIRE) -- XPRESSPA GROUP, INC. (NASDAQ: XSPA) (“XPRESSPA” OR THE “COMPANY”), A HEALTH AND WELLNESS COMPANY, TODAY ANNOUNCED THAT IT HAS ENTERED INTO SECURITIES PURCHASE AGREEMENTS WITH SEVERAL HEALTHCARE-FOCUSED AND OTHER INSTITUTIONAL INVESTORS TO PURCHASE 24,509,806 OF ITS SHARES OF COMMON STOCK (OR COMMON STOCK EQUIVALENTS IN LIEU THEREOF) AND SHORT-TERM WARRANTS TO PURCHASE UP TO AN AGGREGATE OF 24,509,806 SHARES OF COMMON STOCK, IN A REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES. THE COMBINED PURCHASE PRICE FOR ONE SHARE OF COMMON STOCK (OR COMMON STOCK EQUIVALENT) AND A WARRANT TO PURCHASE ONE SHARE OF COMMON STOCK IS $1.70. THE WARRANTS HAVE AN EXERCISE PRICE OF $1.70 PER SHARE, WILL BE IMMEDIATELY EXERCISABLE, AND WILL EXPIRE 24 MONTHS FROM THE ISSUE DATE.
|
XPRESSPA GROUP ANNOUNCES $41.66 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-17 08:30:00
| null |
XPRESCHECK TESTING CENTERS WILL KICKOFF ON-SITE TESTING FOR SELECT UNITED TRAVEL ROUTES AT NEWARK LIBERTY INTERNATIONAL AIRPORT AND DENVER INTERNATIONAL AIRPORT XPRESCHECK TESTING CENTERS WILL KICKOFF ON-SITE TESTING FOR SELECT UNITED TRAVEL ROUTES AT NEWARK LIBERTY INTERNATIONAL AIRPORT AND DENVER INTERNATIONAL AIRPORT
|
XPRESSPA GROUP ANNOUNCES PARTNERSHIP WITH UNITED AIRLINES FOR COVID-19 TESTING WITH XPRESCHECK TESTING FACILITIES
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-16 08:30:00
| null |
LOCATED WITHIN CONCOURSE B, POST SECURITY LOCATED WITHIN CONCOURSE B, POST SECURITY
|
XPRESCHECK™ COVID-19 TESTING FACILITY OPENS AT DENVER INTERNATIONAL AIRPORT TODAY
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-07 08:30:00
| null |
EXPECTED TO COMMENCE OPERATIONS BY MID-DECEMBER
|
XPRESSPA GROUP HAS BEGUN CONSTRUCTION OF NEW XPRESCHECK™ COVID-19 POP-UP TESTING FACILITY AT DENVER INTERNATIONAL AIRPORT
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-12-04 08:30:00
| null |
NEW YORK, DEC. 04, 2020 (GLOBE NEWSWIRE) -- XPRESSPA GROUP, INC. (NASDAQ: XSPA) (“XPRESSPA” OR THE “COMPANY”), A HEALTH AND WELLNESS COMPANY, TODAY ANNOUNCED THAT IT HAS APPOINTED JAMES BERRY AS ITS NEW CHIEF FINANCIAL OFFICER, EFFECTIVE DECEMBER 14, 2020. THE COMPANY ALSO ANNOUNCED THAT IT IS PROMOTING SCOTT MILFORD, WHO HAS SERVED AS CHIEF PEOPLE OFFICER SINCE JOINING THE COMPANY IN JULY 2019, TO THE ROLE OF CHIEF OPERATING OFFICER.
|
XPRESSPA GROUP NAMES JAMES BERRY AS CHIEF FINANCIAL OFFICER; SCOTT MILFORD PROMOTED TO CHIEF OPERATING OFFICER
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-23 08:30:00
| null |
FIRST XPRESCHECK IN THE WEST TO COMMENCE OPERATIONS BEFORE HOLIDAY TRAVEL SEASON FIRST XPRESCHECK IN THE WEST TO COMMENCE OPERATIONS BEFORE HOLIDAY TRAVEL SEASON
|
XPRESSPA GROUP OPENS XPRESCHECK™ COVID-19 TESTING FACILITY WITH THE CITY OF PHOENIX AVIATION DEPARTMENT AT PHOENIX SKY HARBOR INTERNATIONAL AIRPORT TODAY
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-11-13 08:30:00
| null |
NEW YORK, NOV. 13, 2020 (GLOBE NEWSWIRE) -- XPRESSPA GROUP, INC. (NASDAQ: XSPA) (“XPRESSPA” OR THE “COMPANY”), A HEALTH AND WELLNESS COMPANY, TODAY ANNOUNCED THAT XPRESCHECK HAS BEEN NAMED A STATE OF HAWAII TRUSTED TESTING PARTNER.
|
XPRESCHECK™ NAMED STATE OF HAWAII TRUSTED TESTING PARTNER
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-08-19 20:30:00
| null |
XPRESSPA GROUP PROVIDES BUSINESS UPDATE AND ANNOUNCES SECOND QUARTER 2020 FINANCIAL RESULTS.XPRESSPA GROUP INC - PREPARING TO IMPLEMENT RAPID COVID-19 TESTING AND BEGIN EXPANDING INTO ADDITIONAL HEALTH AND WELLNESS SERVICES.XPRESSPA GROUP - IN NEAR-TERM, LOOKING TO EXPAND TESTING TO OTHER COMMUNICABLE DISEASES AS WELL AS ADMINISTER VACCINATIONS FOR SEASONAL FLU.XPRESSPA GROUP - REPORTED DE MINIMIS REVENUES DURING 3 MONTHS ENDED JUNE 30, OF $143,000 VERSUS $12.9 MILLION IN CORRESPONDING PERIOD IN 2019.XPRESSPA GROUP INC QTRLY NET LOSS OF $58.5 MILLION COMPARED TO NET LOSS OF $6.1 MILLION IN PRIOR YEAR Q2.
|
XPRESSPA REPORTS QTRLY NET LOSS OF $58.5 MLN
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-07-24 18:30:00
| null |
XPRESSPA GROUP INC - FILES FOR MIXED SHELF OF UP TO $200 MILLION.
|
XPRESSPA GROUP FILES FOR MIXED SHELF OF UP TO $200 MILLION
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-07-17 18:30:00
| null |
XPRESSPA GROUP INC FILES FOR RESALE OF UP TO 10.5 MILLION SHARES OF COMMON STOCK - SEC FILING.
|
XPRESSPA GROUP INC FILES FOR RESALE OF UP TO 10.5 MILLION SHARES OF COMMON STOCK
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-07-06 19:30:00
| null |
Q1 REVENUE $7.7 MILLION VERSUS $12.2 MILLION.Q1 SAME STORE SALES FELL 26.5 PERCENT.XPRESSPA GROUP - IS IN ACTIVE DISCUSSIONS WITH MULTIPLE U.S. AIRPORTS TO OPEN NEW TESTING CENTERS OR CONVERT EXISTING SPAS, TO XPRESCHECK FACILITIES.QTRLY NET LOSS OF $10.7 MILLION COMPARED TO NET LOSS OF $2.8 MILLION IN Q1 2019.
|
XPRESSPA SAYS Q1 SAME STORE SALES FELL 26.5 PERCENT
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-06-17 10:30:00
| null |
XPRESSPA GROUP ANNOUNCES $40 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES.XPRESSPA GROUP - ENTERED INTO SECURITIES PURCHASE AGREEMENTS WITH INVESTORS TO PURCHASE 7.6 MILLION OF COMMON STOCK.XPRESSPA GROUP - ALSO AGREED TO ISSUE TO INVESTORS SHORT-TERM WARRANTS TO PURCHASE UP TO 7.6 MILLION OF COMMON STOCK IN CONCURRENT PRIVATE PLACEMENT.XPRESSPA GROUP - COMBINED PURCHASE PRICE FOR ONE COMMON STOCK & WARRANT TO PURCHASE ONE SHARE OF COMMON STOCK IS $5.253.
|
XPRESSPA GROUP ANNOUNCES $40 MLN REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-05-22 11:30:00
| null |
XPRESSPA SIGNS CONTRACT WITH JFK INTERNATIONAL AIR TERMINAL LLC FOR COVID-19 SCREENING AND TESTING LOCATION.XPRESSPA GROUP - AGREEMENT WITH JFKIAT FOR NEW MODULAR CONSTRUCTED TESTING FACILITY WITHIN TERMINAL.
|
XPRESSPA SIGNS CONTRACT WITH JFK INTERNATIONAL AIR TERMINAL FOR COVID-19 SCREENING AND TESTING LOCATION
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-04-03 19:30:00
| null |
XPRESSPA GROUP - PROSPECTUS RELATES TO RESALE OF UP TO AGGREGATE OF 17.3 MILLION SHARES OF COMMON STOCK - SEC FILING.
|
XPRESSPA GROUP SAYS PROSPECTUS RELATES TO RESALE OF UP TO AGGREGATE OF 17.3 MLN SHARES OF COMMON STOCK
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Press Release 0 2CRSI.PA
1 2CRSI.PA
2 2CRSI.PA
3 2CRSI.PA
4 2CRSI.PA
...
83 ZYXI
84 ZYXI
85 ZYXI
0 ZZZ.TO
1 ZZZ.TO
Name: symbol, Length: 320040, dtype: object
|
2020-01-14 10:30:00
| null |
XPRESSPA GROUP INC- SEES PRELIMINARY Q4 2019 DECEMBER DOMESTIC COMPARABLE STORE SALES UP 10.2%.XPRESSPA GROUP INC- SEES PRELIMINARY Q4 2019 DOMESTIC COMPARABLE STORE SALES INCREASED 7.7%.
|
XPRESSPA GROUP INC SEES PRELIMINARY Q4 2019 DECEMBER DOMESTIC COMPARABLE STORE SALES UP 10.2%
|
XSPA
|
a5c0a04e-eb88-4264-9cb2-fb3140e63537
|
PressRelease
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.